<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">PEN</journal-id>
<journal-id journal-id-type="hwp">sppen</journal-id>
<journal-id journal-id-type="nlm-ta">JPEN J Parenter Enteral Nutr</journal-id>
<journal-title>Journal of Parenteral and Enteral Nutrition</journal-title>
<issn pub-type="ppub">0148-6071</issn>
<issn pub-type="epub">1941-2444</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0148607112467821</article-id>
<article-id pub-id-type="publisher-id">10.1177_0148607112467821</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Tutorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Role of the ω-3 Fatty Acid DHA in the Human Life Cycle</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Carlson</surname><given-names>Sarah J.</given-names></name>
<degrees>MD, MSc</degrees>
<xref ref-type="aff" rid="aff1-0148607112467821">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fallon</surname><given-names>Erica M.</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0148607112467821">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kalish</surname><given-names>Brian T.</given-names></name>
<xref ref-type="aff" rid="aff1-0148607112467821">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gura</surname><given-names>Kathleen M.</given-names></name>
<degrees>PharmD</degrees>
<xref ref-type="aff" rid="aff2-0148607112467821">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Puder</surname><given-names>Mark</given-names></name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0148607112467821">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0148607112467821"><label>1</label>Department of Surgery and the Vascular Biology Program</aff>
<aff id="aff2-0148607112467821"><label>2</label>Department of Pharmacy, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts</aff>
<author-notes>
<corresp id="corresp1-0148607112467821">Mark Puder, MD, PhD, Boston Children’s Hospital, 300 Longwood Ave, Fegan Building, 3rd Floor, Boston, MA 02115, USA. Email: <email>Mark.puder@childrens.harvard.edu</email>.</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>37</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>22</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>10</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© 2012 American Society for Parenteral and Enteral Nutrition</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">The American Society for Parenteral and Enteral Nutrition</copyright-holder>
</permissions>
<abstract>
<p>Dietary consumption of the essential fatty acids linoleic acid (LA; ω-6) and α-linolenic acid (ALA; ω-3) is necessary for human growth and development. In the past 150 years, the average Western diet has changed dramatically such that humans today consume a much higher proportion of ω-6 fatty acids relative to ω-3 fatty acids than ever before. The importance of ω-3 fatty acids in human development has been well established in fetal and neonatal development, with brain and retinal tissues highly dependent on ω-3 fatty acids, specifically docosahexaenoic acid (DHA) for membrane fluidity and signal transduction. In childhood, ω-3s have been shown to contribute to ongoing cognitive development and may be involved in metabolic programming of bone turnover and adipogenesis. ω-3s may also play important roles in adult neurophysiology and disease prevention.</p>
</abstract>
<kwd-group>
<kwd>neonates</kwd>
<kwd>lipids</kwd>
<kwd>fatty acids</kwd>
<kwd>pediatrics</kwd>
<kwd>pregnancy</kwd>
<kwd>geriatrics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Humans depend on the dietary consumption of fats, in the form of fatty acids, for growth and development. There are 4 basic types of fatty acids, classified according to the number and type of carbon double bonds present in their chemical structures. Fatty acids without double bonds are known as saturated, whereas those with double bonds are referred to as unsaturated fatty acids. Polyunsaturated fatty acids (PUFAs) contain multiple double carbon bonds and are classified by the location of the first double bond within their structure. ω-3 PUFAs refer to those fatty acids with the first double bond between the third and fourth carbon atoms, whereas ω-6 fatty acids have the first double bond between the sixth and seventh carbons.</p>
<p>Linoleic acid (LA; ω-6) and α-linolenic acid (ALA; ω-3) are traditionally recognized as the “essential” fatty acids (EFAs), as they must be consumed in the diet and cannot be synthesized from other metabolic precursors.<sup><xref ref-type="bibr" rid="bibr1-0148607112467821">1</xref>,<xref ref-type="bibr" rid="bibr2-0148607112467821">2</xref></sup> These fatty acids give rise to downstream molecules, which are incorporated into cell membranes and regulate cellular signaling cascades, pro- and anti-inflammatory pathways, protein function, and gene expression. Once consumed, LA is metabolized via a series of desaturation and elongation steps to arachidonic acid (AA), which, in the presence of physiologic stimuli such as growth factors and hormones, gives rise to specific proinflammatory prostaglandins and leukotrienes. These prostaglandins and leukotrienes in turn act locally via G-protein-coupled receptors to recruit neutrophils and regulate platelet aggregation and vascular tone.<sup><xref ref-type="bibr" rid="bibr3-0148607112467821">3</xref><xref ref-type="bibr" rid="bibr4-0148607112467821"/>-<xref ref-type="bibr" rid="bibr5-0148607112467821">5</xref></sup> ALA uses the same enzymes of desaturation and elongation to give rise to its downstream products, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). DHA and EPA in turn produce a class of molecules known as specialized proresolving mediators (SPMs), including resolvins, protectins, and maresins, which play a key role in facilitating the active resolution of inflammation in a variety of disease states, including colitis, acute lung injury, and myocardial ischemia. These SPMs have been implicated as key molecules that may contribute to the anti-inflammatory properties of ω-3 fatty acids (<xref ref-type="fig" rid="fig1-0148607112467821">Figure 1</xref>).<sup><xref ref-type="bibr" rid="bibr6-0148607112467821">6</xref><xref ref-type="bibr" rid="bibr7-0148607112467821"/><xref ref-type="bibr" rid="bibr8-0148607112467821"/>-<xref ref-type="bibr" rid="bibr9-0148607112467821">9</xref></sup></p>
<fig id="fig1-0148607112467821" position="float">
<label>Figure 1.</label>
<caption>
<p>Metabolic pathways of omega-6 and omega-3 fatty acids.</p>
</caption>
<graphic xlink:href="10.1177_0148607112467821-fig1.tif"/>
</fig>
<p>Historically, humankind has consumed a diet rich in ω-3 sources of fat, including a variety of fish, seeds, and nuts. Since the Industrial Revolution, however, increased processing of foods has led to a dramatic increase in the production and availability of ω-6–rich sources of fat, found in vegetable oils and processed foods. The average caloric intake of the modern Western diet consists of over 70% foods that were rarely or never consumed by our hunter-gatherer ancestors, including refined sugars, processed fats, dairy products, and grains. The result of this shift is a dramatic change in the ratio of ω-6 to ω-3 fats consumed by humans—formerly approximately 1:1 and now estimated to be 15:1 to 20:1 in the typical Western diet.<sup><xref ref-type="bibr" rid="bibr10-0148607112467821">10</xref></sup> These dietary changes have occurred rapidly over the past 100 years, and the diet consumed by most humans today is drastically different from that consumed by our ancestors.<sup><xref ref-type="bibr" rid="bibr10-0148607112467821">10</xref><xref ref-type="bibr" rid="bibr11-0148607112467821"/>-<xref ref-type="bibr" rid="bibr12-0148607112467821">12</xref></sup> The implications of these changes are not yet fully understood, but an imbalance of ω-6 to ω-3 has been implicated in a variety of diseases and inflammatory states.<sup><xref ref-type="bibr" rid="bibr10-0148607112467821">10</xref></sup> Kang et al<sup><xref ref-type="bibr" rid="bibr13-0148607112467821">13</xref></sup> investigated the importance of the ω-6/ω-3 balance, demonstrating that rat cardiomyocytes are able to form all ω-3s from ω-6 fatty acids when treated in vitro with complementary DNA (cDNA) from <italic>Caenorhabditis elegans</italic> encoding an ω-3 fatty acid desaturase. In treated cells, ω-6 LA was converted to ω-3 ALA, and AA was converted to EPA such that at equilibrium, the ratio of ω-6 to ω-3 was close to 1:1. Further studies by Ge et al<sup><xref ref-type="bibr" rid="bibr14-0148607112467821">14</xref></sup> demonstrated that human breast cancer cells expressing the same ω-3 desaturase reached equilibrium at an ω-6 to ω-3 ratio of approximately 1:1 and underwent apoptosis, whereas control cancer cells with a high (12:1) ω-6 to ω-3 ratio continued to proliferate. These studies suggest a physiologic benefit of maintaining a balance of ω-6 to ω-3 closer to that of our ancestors.</p>
<p>The purpose of this review is to examine ω-3 fatty acids as they pertain to normal human development; as such, diseases affected by ω-3s will not be discussed in detail. Herein we examine the role of ω-3 fatty throughout the human life cycle.</p>
<sec id="section1-0148607112467821">
<title>Fetal and Neonatal Development</title>
<p>Fetal development represents the highest period of growth and metabolic turnover in the human life cycle. The average human brain weight increases nearly 60-fold from the second trimester of gestation to age 2 years, from approximately 20–1200 g. During this time, neurons in the fetal brain experience rapid myelination and maturation of synapses.<sup><xref ref-type="bibr" rid="bibr15-0148607112467821">15</xref></sup> In 1980, Clandinin et al<sup><xref ref-type="bibr" rid="bibr16-0148607112467821">16</xref></sup> demonstrated that ALA and LA levels decrease in the infant brain during the third trimester of pregnancy, whereas accretion of DHA and AA markedly increases. Later, Martinez<sup><xref ref-type="bibr" rid="bibr17-0148607112467821">17</xref></sup> quantified the levels of various PUFAs in neonatal tissues and found that from the second trimester to the first 2 years of life, accretion of DHA and AA in the brain increases by nearly 30-fold. These observations led researchers to further examine the importance of DHA and AA for human brain development. Since that time, DHA has been the only ω-3 fatty acid found in significant quantities in the brain and retina, comprising 50% of neuronal plasma membranes by weight.<sup><xref ref-type="bibr" rid="bibr18-0148607112467821">18</xref></sup> In neuronal tissues, DHA optimizes the fluidity of cell membranes and modulates neurotransmitter physiology, including signal transduction by acetylcholine, dopamine, and serotonin, which have major implications in cognition, vision, and behavior.<sup><xref ref-type="bibr" rid="bibr19-0148607112467821">19</xref><xref ref-type="bibr" rid="bibr20-0148607112467821"/>-<xref ref-type="bibr" rid="bibr21-0148607112467821">21</xref></sup></p>
<p>To characterize this physiology, Innis et al<sup><xref ref-type="bibr" rid="bibr19-0148607112467821">19</xref></sup> randomized pregnant female rats to 1 of 3 diets with fat calories provided as purified fish oil, soybean oil, or safflower oil, and the brain composition of their newborn progeny was evaluated. Dietary fat composition was found to have a marked effect on the concentrations of DHA and AA in the neuronal growth cone membrane phospholipids of the newborn rats, with significantly higher DHA present in offspring of animals fed fish oil compared with safflower or soybean oil. In addition, dopamine was found to be significantly lower in offspring of fish oil–fed animals, with increasing concentrations of DHA in the neural growth cone associated with decreasing brain dopamine concentration. Serotonin was higher in the brains of offspring of animals fed safflower oil when compared with soybean or fish oil. These studies suggest that maternal dietary fatty acid intake may alter not only growth of fetal neurons but the biochemistry of neurotransmitters as well. Another study by Zimmer et al<sup><xref ref-type="bibr" rid="bibr21-0148607112467821">21</xref></sup> demonstrated that rats fed an ω-3 fatty acid–deficient diet have significantly altered mesolimbic and mesocortical activity (as measured by dopamine release from these regions of the rat brain) compared with control rats, suggesting that ω-3 status may have an impact on behavior. Zicker et al<sup><xref ref-type="bibr" rid="bibr22-0148607112467821">22</xref></sup> fed beagle puppies 1 of 3 diets containing low, moderate, or high levels of DHA (&lt;0.01%, 0.095%, or 0.19% DHA by weight) and found that puppies on the high DHA diet had significantly improved visual contrast discrimination, reversal task learning, and psychomotor performance compared with the moderate- or low-level DHA diet animals. These studies suggest that the impact of DHA on behavior and cognitive function early in life may be attributed in part to the migration of neuronal cells during development. In the setting of ω-3 fatty acid deficiency, Yavin et al<sup><xref ref-type="bibr" rid="bibr23-0148607112467821">23</xref></sup> demonstrated markedly delayed migration of neuronal cells in developing embryonic brains of offspring of rats fed an ALA-deficient diet (0.01% ALA in deficient diet vs 3% ALA in adequate diet, with dietary compositions otherwise similar). Human studies have similarly suggested these results may translate to measurable differences in the cognitive development of infants based on maternal dietary DHA intake. In a study of 2-day old infants, Helland et al<sup><xref ref-type="bibr" rid="bibr24-0148607112467821">24</xref></sup> found that higher levels of DHA in umbilical cord blood at birth were associated with more mature electroencephalogram (EEG) patterns at 2 days of age when compared with age-matched infants with lower levels of DHA in cord blood. Taken together, these studies point to the importance of DHA for early brain and retinal development and neurophysiology.</p>
<p>All EFAs required for fetal growth must be obtained from the mother’s diet and conferred to the fetus via placental transfer in the form of long-chain PUFAs.<sup><xref ref-type="bibr" rid="bibr25-0148607112467821">25</xref></sup> In utero transfer of EFAs to the fetus is a complex process, the details of which are still poorly understood. However, recent studies suggest that the placenta itself may modulate the gradient between maternal and fetal fatty acids.<sup><xref ref-type="bibr" rid="bibr25-0148607112467821">25</xref><xref ref-type="bibr" rid="bibr26-0148607112467821"/><xref ref-type="bibr" rid="bibr27-0148607112467821"/>-<xref ref-type="bibr" rid="bibr28-0148607112467821">28</xref></sup> It is known that PUFAs are preferentially transferred to the fetus at the expense of the mother’s own physiologic stores. This preferential transfer is termed <italic>biomagnification</italic>,<sup><xref ref-type="bibr" rid="bibr29-0148607112467821">29</xref></sup> with a predominance of maternal AA consumed by the fetus primarily in early pregnancy followed by DHA in the third trimester and postpartum during lactation. Placental transfer of DHA and AA is a multistep process by which fatty acids are transported in nonesterified forms across the placental membrane.<sup><xref ref-type="bibr" rid="bibr26-0148607112467821">26</xref><xref ref-type="bibr" rid="bibr27-0148607112467821"/>-<xref ref-type="bibr" rid="bibr28-0148607112467821">28</xref></sup> Maternal fatty acids in the form of lipoproteins are hydrolyzed by lipoprotein lipase, an enzyme found on the maternal side of the placental interface. Fatty acids then cross the placental membranes as nonesterified fatty acids. Transport of the fatty acids depends on the concentration gradient of the nonesterified fatty acids between the maternal and fetal circulations.<sup><xref ref-type="bibr" rid="bibr2-0148607112467821">2</xref>,<xref ref-type="bibr" rid="bibr30-0148607112467821">30</xref>,<xref ref-type="bibr" rid="bibr31-0148607112467821">31</xref></sup> In a series of experiments using stable isotope <sup><xref ref-type="bibr" rid="bibr13-0148607112467821">13</xref></sup>C-DHA, Larque et al<sup><xref ref-type="bibr" rid="bibr32-0148607112467821">32</xref></sup> demonstrated that DHA is preferentially transferred (over LA, oleic acid, and palmitic acid) across the placenta from maternal to fetal circulation. Subsequently, Haggarty et al<sup><xref ref-type="bibr" rid="bibr33-0148607112467821">33</xref></sup> demonstrated an in vitro effect of preferential transport of DHA across the placenta (DHA &gt; AA &gt; ALA &gt; LA), further suggesting the importance of DHA in the neurological development of the fetus.</p>
<p>The fetus is capable of forming DHA from its precursor ALA via a 2-step desaturation process, but the enzymes necessary to carry out this process are present only in low levels in the fetal liver during gestation, and preformed DHA from the mother is much more efficient in supporting the uptake of DHA into the developing brain and retina.<sup><xref ref-type="bibr" rid="bibr34-0148607112467821">34</xref><xref ref-type="bibr" rid="bibr35-0148607112467821"/>-<xref ref-type="bibr" rid="bibr36-0148607112467821">36</xref></sup> Interestingly, no data suggest a similar physiologic challenge in the production of AA from its precursor LA. This supports the importance of DHA itself, and not just its ω-3 precursor ALA, in the diet of expectant mothers. One study by Su et al<sup><xref ref-type="bibr" rid="bibr37-0148607112467821">37</xref></sup> found fetal plasma DHA to be approximately 8 times more effective as a substrate for brain DHA accretion than plasma ALA using 13-C tracers in pregnant baboons. The transfer of DHA increases markedly in the third trimester of pregnancy,<sup><xref ref-type="bibr" rid="bibr25-0148607112467821">25</xref></sup> with accretion of DHA in fetal tissues doubling from 35–40 weeks’ gestation.<sup><xref ref-type="bibr" rid="bibr38-0148607112467821">38</xref></sup> Given this dramatic increase in DHA transfer at the end of gestation, it is evident that the preterm infant faces a particularly difficult challenge in obtaining sufficient DHA for continued brain development.</p>
<p>Rapid neuronal growth is not limited to the developing fetus. The period from 34 weeks’ gestation through the first 2 years of life represents an accelerated period of growth of dendrites and the formation of synapses in the brain.<sup><xref ref-type="bibr" rid="bibr39-0148607112467821">39</xref></sup> After birth, however, the plasma DHA and AA levels decline, and the neonate must obtain these PUFAs from the diet alone, making the provision of sufficient DHA and AA a significant challenge in preterm infants.<sup><xref ref-type="bibr" rid="bibr2-0148607112467821">2</xref>,<xref ref-type="bibr" rid="bibr25-0148607112467821">25</xref></sup> Breast milk, although highly reflective of the maternal diet,<sup><xref ref-type="bibr" rid="bibr40-0148607112467821">40</xref></sup> provides the neonate with only 20% of the total amount of DHA transferred from the placenta through maternal circulation.<sup><xref ref-type="bibr" rid="bibr2-0148607112467821">2</xref></sup> Studies have shown that maternal supplementation of dietary DHA during lactation increases the level of DHA in milk, although the long-term implications of postpartum maternal DHA supplementation for neonatal health remain unclear.<sup><xref ref-type="bibr" rid="bibr25-0148607112467821">25</xref></sup> With regard to formula, one prospective randomized controlled trial by O’Connor et al<sup><xref ref-type="bibr" rid="bibr41-0148607112467821">41</xref></sup> found that preterm infants fed formula supplemented with DHA and AA (in the form of fish oil plus fungal oil or fish oil plus egg triglyceride with DHA and AA comprising 0.26% and 0.42% of total fatty acids for the preterm formula and 0.16% and 0.44% of total fatty acids for the term formula, respectively) have higher Bayley mental developmental inventory scores and MacArthur Communicative Inventory scores at 12 months of age when compared with age-matched infants who did not receive supplementation. In addition, studies have shown improved visual acuity among infants fed DHA-supplemented formula during the first months of life.<sup><xref ref-type="bibr" rid="bibr42-0148607112467821">42</xref>,<xref ref-type="bibr" rid="bibr43-0148607112467821">43</xref></sup></p>
</sec>
<sec id="section2-0148607112467821">
<title>Childhood</title>
<p>There is limited literature on the relationship between fatty acid consumption and health outcomes in children &gt;2 years. However, it is well known that an adequate and balanced supply of AA and DHA is required for normal childhood growth and cognitive development. The European Food Safety Authority recommends that infants &gt;6 months to 2 years should consume 100 mg/d of DHA as part of a balanced diet, whereas children 2–18 years of age should have daily DHA and EPA intakes similar to that of the adult population (approximately 250 mg/d).</p>
<p>Given the significance of PUFAs on cognition and vision in the neonatal period, numerous investigators have evaluated the same associations in early and mid-childhood. Several studies have examined the effect of maternal consumption of ω-3 fatty acids during pregnancy and breastfeeding on vision and neurodevelopment later in childhood.<sup><xref ref-type="bibr" rid="bibr44-0148607112467821">44</xref><xref ref-type="bibr" rid="bibr45-0148607112467821"/><xref ref-type="bibr" rid="bibr46-0148607112467821"/><xref ref-type="bibr" rid="bibr47-0148607112467821"/>-<xref ref-type="bibr" rid="bibr48-0148607112467821">48</xref></sup> Jensen et al<sup><xref ref-type="bibr" rid="bibr44-0148607112467821">44</xref></sup> found that 5-year-old children whose mothers were supplemented with 200 mg/d of DHA while breastfeeding, from delivery until 4 months postpartum, performed better on attention tasks than children of mothers who were supplemented with vegetable oil. Boucher et al<sup><xref ref-type="bibr" rid="bibr49-0148607112467821">49</xref></sup> prospectively found that higher umbilical cord blood DHA levels (&gt;3.43% of fatty acids) were associated with improved performance on a continuous visual recognition task in 154 Inuit children aged 10–13 years when compared with children with lower cord blood DHA levels (&lt;3.42% of fatty acids).</p>
<p>Such prospective studies are in short supply; as a result, retrospective studies have attempted to correlate neurodevelopmental outcomes with ω-3 exposure via umbilical cord samples or food frequency questionnaires. For example, Hibbeln et al<sup><xref ref-type="bibr" rid="bibr45-0148607112467821">45</xref></sup> found that maternal seafood intake of more than 340 g per week during pregnancy had beneficial effects on childhood communication skills measured by verbal intelligence quotient (IQ) in children aged 6 months to 8 years. Similarly, Bakker et al<sup><xref ref-type="bibr" rid="bibr46-0148607112467821">46</xref></sup> noted a significant, positive relation between umbilical plasma DHA concentrations and the Maastricht Motor Test total and quality scores at 7 years of age. There are few randomized, prospective studies on the effect of childhood interventions to increase ω-3 intake. Minns et al<sup><xref ref-type="bibr" rid="bibr50-0148607112467821">50</xref></sup> found that toddlers consuming formula with 130 mg DHA per day for 60 days had fewer adverse events (eg, strep throat, cough, upper respiratory infection) and a lower incidence of respiratory illness compared with toddlers consuming the formula without DHA.</p>
<p>Other studies of the impact of maternal fish or ω-3 consumption on childhood outcomes have yielded null results.<sup><xref ref-type="bibr" rid="bibr51-0148607112467821">51</xref>,<xref ref-type="bibr" rid="bibr52-0148607112467821">52</xref></sup> For instance, Ghys et al<sup><xref ref-type="bibr" rid="bibr52-0148607112467821">52</xref></sup> assessed the cognitive development (by administration of the Groningen Development Scale) of 128 four-year-old children and found no association between umbilical venous plasma or red blood cell phospholipid DHA and AA levels and cognitive outcomes. Recent meta-analyses underscore methodological limitations of the existing randomized controlled trials and epidemiologic studies. These limitations include the challenges in quantifying fatty acid exposure and measuring neurodevelopmental outcomes, as well as the generalizability of the studies. In addition, the effect sizes of epidemiologic studies to date have been relatively modest.<sup><xref ref-type="bibr" rid="bibr51-0148607112467821">51</xref>,<xref ref-type="bibr" rid="bibr53-0148607112467821">53</xref></sup></p>
<p>There is a small but growing body of evidence on the programming of long-term childhood metabolic outcomes due to perinatal fatty acid intake. Donahue et al<sup><xref ref-type="bibr" rid="bibr54-0148607112467821">54</xref></sup> demonstrated that increased maternal serum DHA and EPA has been associated with lower childhood adiposity at 3 years of age in a large prospective cohort of mother-child pairs. In rodent studies, disequilibrium in PUFA metabolism has been implicated in adipogenesis.<sup><xref ref-type="bibr" rid="bibr55-0148607112467821">55</xref></sup> High LA intake raises AA levels, which drives prostacyclin production and activates pathways critical for adipogenesis, including peroxisome proliferator-activated receptors (PPARs). In contrast, DHA and EPA are known to increase production of leptin, a satiety hormone. High-fat or high-carbohydrate feeding during pregnancy is associated with increased muscle, adipose, and liver lipid deposition, as well as altered insulin secretion in young rodent offspring.<sup><xref ref-type="bibr" rid="bibr56-0148607112467821">56</xref>,<xref ref-type="bibr" rid="bibr57-0148607112467821">57</xref></sup> The role of fatty acid exposure on childhood metabolism may not be limited to adipogenesis. Recently, a higher concentration of ω-3 fatty acids in maternal plasma has been associated with more favorable bone mineral measures at 4 years of age.<sup><xref ref-type="bibr" rid="bibr58-0148607112467821">58</xref></sup></p>
<p>DHA has been implicated in the treatment of certain childhood diseases such as attention-deficit hyperactivity disorder,<sup><xref ref-type="bibr" rid="bibr59-0148607112467821">59</xref></sup> upper respiratory illness, and allergy<sup><xref ref-type="bibr" rid="bibr60-0148607112467821">60</xref></sup>; however, these potential therapeutic relationships are beyond the scope of this review and will not be discussed herein.</p>
</sec>
<sec id="section3-0148607112467821">
<title>Adulthood</title>
<p>In adults, low intake of ω-3 PUFAs has been associated with many disease states, including cardiovascular, inflammatory/autoimmune, neurodevelopmental, and psychiatric disorders.<sup><xref ref-type="bibr" rid="bibr61-0148607112467821">61</xref>,<xref ref-type="bibr" rid="bibr62-0148607112467821">62</xref></sup> In evaluating the effect of physiologic levels of ω-3 fatty acids in adulthood, Muldoon et al<sup><xref ref-type="bibr" rid="bibr62-0148607112467821">62</xref></sup> studied 280 community volunteers (aged 35–54 years) without neuropsychiatric disease and not taking fish oil supplements, assessed 5 major dimensions of cognitive functioning, and found higher serum phospholipid DHA (as a percentage of the total fatty acid pool, measured in mol %) to be associated with significantly improved nonverbal reasoning and mental flexibility, working memory, and vocabulary on neuropsychological tests. The study also measured ALA and EPA in serum phospholipids yet found EPA was only marginally associated with working memory and ALA was unrelated to any measure of cognitive performance. DHA was the only ω-3 PUFA with significant improvement in neuropsychological testing performance, suggesting that it has an effect on brain health even into middle adulthood. These findings are supported by earlier epidemiologic studies of self-reported fatty fish intake<sup><xref ref-type="bibr" rid="bibr63-0148607112467821">63</xref>,<xref ref-type="bibr" rid="bibr64-0148607112467821">64</xref></sup> and fatty acid analyses<sup><xref ref-type="bibr" rid="bibr65-0148607112467821">65</xref></sup> of middle-aged European and American adults, which found that dietary intake of ω-3 fatty acids was related to cognitive performance. In 2004, Kalmijn et al<sup><xref ref-type="bibr" rid="bibr63-0148607112467821">63</xref></sup> conducted a cross-sectional population-based study of 1613 adults (aged 45–70 years) and evaluated memory, psychomotor speed, order information processing, and overall cognition in association with self-reported food consumption. Findings revealed that intake of EPA and DHA was inversely related to the risk of impaired cognitive function and speed. A few years later, Beydoun et al<sup><xref ref-type="bibr" rid="bibr65-0148607112467821">65</xref></sup> prospectively evaluated plasma fatty acids in cholesterol esters and phospholipids in 2251 adults (aged 50–65 years) who underwent delayed word recall, psychomotor speed, and verbal fluency evaluation and found that higher ω-3 fatty acids were associated with reduced risk of cognitive decline in verbal fluency, especially in hypertensive and dyslipidemic patients. These findings suggest that the downstream products of ω-3 fatty acid metabolism are important and contribute to enhanced cognitive performance even into middle adulthood.</p>
<p>Small animal studies have similarly shown that ω-3 fatty deficiency results in cognitive deficits during neurological testing, suggesting that learning performance and subsequent cognitive behavior may be related to brain DHA status even beyond the perinatal and early childhood period.<sup><xref ref-type="bibr" rid="bibr66-0148607112467821">66</xref>,<xref ref-type="bibr" rid="bibr67-0148607112467821">67</xref></sup> A recent study by Agrawal et al<sup><xref ref-type="bibr" rid="bibr61-0148607112467821">61</xref></sup> found that a deficiency of dietary ω-3 fatty acids in adult rats resulted in elevated parameters of peripheral insulin resistance and disrupted insulin signaling in the brain, subsequently associated with lowered learning performance. In addition, deficiency of dietary ω-3 fatty acids resulted in increased latency time in a Barnes maze test, indicating memory impairment. The impairment was further enhanced by fructose intake and ameliorated by ω-3 supplementation, suggesting that dietary ω-3 deficiency influences the vulnerability for fructose-induced changes. Results of the Agrawal et al study further suggest that a lack of dietary ω-3 fatty acids may lead to alteration of synaptic plasticity and vulnerability to cognition dysfunction.</p>
<p>An association between the proportion of ω-3 PUFAs within the plasma/erythrocyte membrane fatty acid and cognitive function also has been identified; specifically, higher tissue concentrations (plasma/erythrocyte) of ω-3 PUFAs have been associated with a lower risk of cognitive decline.<sup><xref ref-type="bibr" rid="bibr66-0148607112467821">66</xref>,<xref ref-type="bibr" rid="bibr67-0148607112467821">67</xref></sup> A study by Leeson et al<sup><xref ref-type="bibr" rid="bibr68-0148607112467821">68</xref></sup> found a positive relationship between ω-3 fatty acid status and flow-mediated brachial artery dilatation (endothelium dependent) in young adults (aged 20–28 years) with a history of tobacco use or high levels of fasting insulin, glucose, and/or triglycerides, suggesting that higher physiologic levels of ω-3 fatty acids may protect endothelial function. Similar to how epidemiological studies have found normal dietary intake of fish to relate to coronary artery disease, the aforementioned study evaluated endothelial function resulting from normal dietary variation in young adults. These findings suggest that ω-3 fatty acids from normal dietary intake may have a protective effect on endothelial function in adulthood.</p>
</sec>
<sec id="section4-0148607112467821">
<title>Advanced Age</title>
<p>The aging process leads to functional and physiological changes that result in changing nutrient needs in the elderly. With advancing age, the quantity of food and energy intake significantly decreases and can potentially affect levels of ω-3 fatty acids in serum and tissues.<sup><xref ref-type="bibr" rid="bibr69-0148607112467821">69</xref></sup> In comparison to their role in childhood growth and development, ω-3 fatty acids are known to inhibit hepatic triglyceride synthesis, decrease inflammation, and inhibit platelet aggregation in the elderly.<sup><xref ref-type="bibr" rid="bibr70-0148607112467821">70</xref></sup> Studies to date investigating the role of ω-3 fatty acids in healthy older adults are limited, many with small populations and wide variations in age and state of health. Moreover, it is unclear whether dietary ω-3 intake during gestation and early infancy may affect overall health throughout life, including advanced age. Barker and Martyn<sup><xref ref-type="bibr" rid="bibr71-0148607112467821">71</xref></sup> demonstrated that growth retardation in utero and in infancy is associated with an increased risk of cardiovascular disease later in life, raising the question as to whether ω-3 fatty acid status in gestation and infancy may lead to protection against disease later in life. To date, the effects of ω-3 intake during infancy on health in adulthood and advancing age are unknown.</p>
<p>During the aging process, the human body experiences damage at the molecular, cellular, and organ levels, resulting in dysregulated or diminished function and increased risk of disease and death. ω-3 fatty acids suppress both innate (eg, inflammation) and adaptive (eg, T-cell–mediated) immune responses,<sup><xref ref-type="bibr" rid="bibr72-0148607112467821">72</xref></sup> and elderly individuals may be more sensitive to the immunological properties of ω-3 fatty acids. Pae et al<sup><xref ref-type="bibr" rid="bibr73-0148607112467821">73</xref></sup> found that increases in ω-3 fatty acid intake reduced the production of proinflammatory cytokines interleukin (IL)-1, IL-2, and IL-6 as well as tumor necrosis factor (TNF). Increased ω-3 intake (in the form of fish oil supplementation 2.4 g/d for 3 months) reduced IL-6 in young women (aged 23–33 years) by 30% and in older women (aged 51–68 years) by 60%. Total IL-1β synthesis (as measured by radioimmunoassay) was reduced by 48% in young women in comparison to 90% in older women, whereas TNF was reduced by 58% in young and 70% in older women. Supplementation with ω-3 fatty acids reduced IL-2 production in both groups; however, this reduction was significant only in older women, in whom suppression of IL-2 production and lymphocyte proliferation may not be desirable. Evidence to date does not suggest that ω-3 fatty acids improve immunosenescence in the defense of the host against pathogens.</p>
<p>Some evidence suggests that ω-3 PUFAs may alter the expression of genes that control a variety of biological processes, including neurogenesis, neurotransmission, and refinement of connectivity, which are important in maintaining cognitive health.<sup><xref ref-type="bibr" rid="bibr74-0148607112467821">74</xref>,<xref ref-type="bibr" rid="bibr75-0148607112467821">75</xref></sup> The mechanism of these neuroprotective effects is an area of ongoing research. Wood et al<sup><xref ref-type="bibr" rid="bibr76-0148607112467821">76</xref></sup> demonstrated a relationship between DHA supplementation and upregulation of endocannabinoid system metabolites in murine brains, which function to modulate neurotransmitter release and have been shown to confer neuroprotective effects. In addition, free radical–mediated oxidation of DHA has been shown to activate neuroprostanes and neurofurans, which are potent anti-inflammatory metabolites similar to prostaglandins and may also contribute to the maintenance of brain health in advancing age.<sup><xref ref-type="bibr" rid="bibr77-0148607112467821">77</xref>,<xref ref-type="bibr" rid="bibr78-0148607112467821">78</xref></sup> The importance of DHA-derived neuroprotectin D1 (NPD1) has been demonstrated in the homeostatic regulation of brain cell survival and repair involving neurotrophic, antiapoptotic, and anti-inflammatory signaling. NPD1 synthesis is activated by growth factors and neurotrophins and has important determinant and regulatory interactions with the molecular-genetic mechanisms affecting both β–amyloid precursor protein (β-APP) and amyloid β (Aβ) peptide neurobiology. DHA deficiency or DHA peroxidation appears to contribute to inflammatory signaling, apoptosis, and neuronal dysfunction present in Alzheimer disease.<sup><xref ref-type="bibr" rid="bibr75-0148607112467821">75</xref></sup> Tan et al<sup><xref ref-type="bibr" rid="bibr79-0148607112467821">79</xref></sup> demonstrated in elderly Framingham Study participants (average age 67 ± 9 years) that individuals with red blood cell (RBC) DHA levels in the lowest quartile had lower total brain volume and lower scores on tests of visual memory, executive function, and abstract thinking when compared with individuals in the second to fourth quartiles of RBC DHA level.</p>
<p>Although beyond the scope of this review, DHA has been implicated as protective against a variety of diseases, including heart disease, chronic inflammatory states such as rheumatoid arthritis, and certain types of cancer. The role of supplementation of ω-3 fatty acids in disease prevention is an area of ongoing research.</p>
</sec>
<sec id="section5-0148607112467821">
<title>Conclusion</title>
<p>Humans depend on the consumption of essential fatty acids for growth, development, and the maintenance of cellular pathways essential to life. The balance between ω-6 and ω-3 fatty acids has rapidly changed with the evolution of the typical Western diet, with generally a larger proportion of ω-6 fatty acids consumed by humans today than ever before. Although the implications of this changing balance are in many ways still unclear, the importance of ω-3 fatty acids in fetal and neonatal development cannot be understated, and the role of ω-3s throughout the rest of the human life cycle is important and remains an area of scientific interest for future studies.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>Financial disclosure: none declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0148607112467821">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Innis</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Essential fatty acids in growth and development</article-title>. <source>Progress Lipid Res</source>. <year>1991</year>;<volume>30</volume>(<issue>1</issue>):<fpage>39</fpage>-<lpage>103</lpage>.</citation>
</ref>
<ref id="bibr2-0148607112467821">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Innis</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids</article-title>. <source>J Pediatr</source>. <year>2003</year>;<volume>143</volume>(<issue>4</issue>)(<supplement>suppl</supplement>):<fpage>S1</fpage>-<lpage>S8</lpage>.</citation>
</ref>
<ref id="bibr3-0148607112467821">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haeggstrom</surname><given-names>JZ</given-names></name>
<name><surname>Funk</surname><given-names>CD</given-names></name>
</person-group>. <article-title>Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease</article-title>. <source>Chem Rev</source>. <year>2011</year>;<volume>111</volume>(<issue>10</issue>):<fpage>5866</fpage>-<lpage>5898</lpage>.</citation>
</ref>
<ref id="bibr4-0148607112467821">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harizi</surname><given-names>H</given-names></name>
<name><surname>Corcuff</surname><given-names>JB</given-names></name>
<name><surname>Gualde</surname><given-names>N</given-names></name>
</person-group>. <article-title>Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology</article-title>. <source>Trends Mol Med</source>. <year>2008</year>;<volume>14</volume>(<issue>10</issue>):<fpage>461</fpage>-<lpage>469</lpage>.</citation>
</ref>
<ref id="bibr5-0148607112467821">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Funk</surname><given-names>CD</given-names></name>
</person-group>. <article-title>Prostaglandins and leukotrienes: advances in eicosanoid biology</article-title>. <source>Science</source>. <year>2001</year>;<volume>294</volume>(<issue>5548</issue>):<fpage>1871</fpage>-<lpage>1875</lpage>.</citation>
</ref>
<ref id="bibr6-0148607112467821">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Serhan</surname><given-names>CN</given-names></name>
</person-group>. <article-title>Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source>. <year>2005</year>;<volume>73</volume>(<issue>3-4</issue>):<fpage>141</fpage>-<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr7-0148607112467821">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arita</surname><given-names>M</given-names></name>
<name><surname>Yoshida</surname><given-names>M</given-names></name>
<name><surname>Hong</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid–induced colitis</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>21</issue>):<fpage>7671</fpage>-<lpage>7676</lpage>.</citation>
</ref>
<ref id="bibr8-0148607112467821">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wang</surname><given-names>B</given-names></name>
<name><surname>Gong</surname><given-names>X</given-names></name>
<name><surname>Wan</surname><given-names>JY</given-names></name>
<etal/>
</person-group>. <article-title>Resolvin D1 protects mice from LPS-induced acute lung injury</article-title>. <source>Pulm Pharmacol Ther</source>. <year>2011</year>;<volume>24</volume>(<issue>4</issue>):<fpage>434</fpage>-<lpage>441</lpage>.</citation>
</ref>
<ref id="bibr9-0148607112467821">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Keyes</surname><given-names>KT</given-names></name>
<name><surname>Ye</surname><given-names>Y</given-names></name>
<name><surname>Lin</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Resolvin E1 protects the rat heart against reperfusion injury</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2010</year>;<volume>299</volume>(<issue>1</issue>):<fpage>H153</fpage>-<lpage>H164</lpage>.</citation>
</ref>
<ref id="bibr10-0148607112467821">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simopoulos</surname><given-names>AP</given-names></name>
</person-group>. <article-title>Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects</article-title>. <source>World Rev Nutr Diet</source>. <year>2003</year>;<volume>92</volume>:<fpage>1</fpage>-<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr11-0148607112467821">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>German</surname><given-names>JB</given-names></name>
</person-group>. <article-title>Dietary lipids from an evolutionary perspective: sources, structures and functions</article-title>. <source>Maternal Child Nutr</source>. <year>2011</year>;<volume>7</volume>(<supplement>suppl 2</supplement>):<fpage>2</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr12-0148607112467821">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simopoulos</surname><given-names>AP</given-names></name>
</person-group>. <article-title>Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases</article-title>. <source>Biomed Pharmacother</source>. <year>2006</year>;<volume>60</volume>(<issue>9</issue>):<fpage>502</fpage>-<lpage>507</lpage>.</citation>
</ref>
<ref id="bibr13-0148607112467821">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kang</surname><given-names>ZB</given-names></name>
<name><surname>Ge</surname><given-names>Y</given-names></name>
<name><surname>Chen</surname><given-names>Z</given-names></name>
<etal/>
</person-group>. <article-title>Adenoviral gene transfer of <italic>Caenorhabditis elegans</italic> n-3 fatty acid desaturase optimizes fatty acid composition in mammalian cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2001</year>;<volume>98</volume>(<issue>7</issue>):<fpage>4050</fpage>-<lpage>4054</lpage>.</citation>
</ref>
<ref id="bibr14-0148607112467821">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ge</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>Z</given-names></name>
<name><surname>Landman</surname><given-names>N</given-names></name>
<name><surname>Lo</surname><given-names>EH</given-names></name>
<name><surname>Kang</surname><given-names>JX</given-names></name>
</person-group>. <article-title>Gene transfer of the <italic>Caenorhabditis elegans</italic> n-3 fatty acid desaturase inhibits neuronal apoptosis</article-title>. <source>J Neurochem</source>. <year>2002</year>;<volume>82</volume>(<issue>6</issue>):<fpage>1360</fpage>-<lpage>1366</lpage>.</citation>
</ref>
<ref id="bibr15-0148607112467821">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dobbing</surname><given-names>J</given-names></name>
<name><surname>Sands</surname><given-names>J</given-names></name>
</person-group>. <article-title>Quantitative growth and development of human brain</article-title>. <source>Arch Dis Child</source>. <year>1973</year>;<volume>48</volume>(<issue>10</issue>):<fpage>757</fpage>-<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr16-0148607112467821">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Clandinin</surname><given-names>MT</given-names></name>
<name><surname>Chappell</surname><given-names>JE</given-names></name>
<name><surname>Leong</surname><given-names>S</given-names></name>
<name><surname>Heim</surname><given-names>T</given-names></name>
<name><surname>Swyer</surname><given-names>PR</given-names></name>
<name><surname>Chance</surname><given-names>GW</given-names></name>
</person-group>. <article-title>Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements</article-title>. <source>Early Hum Dev</source>. <year>1980</year>;<volume>4</volume>(<issue>2</issue>):<fpage>131</fpage>-<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr17-0148607112467821">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>M</given-names></name>
</person-group>. <article-title>Tissue levels of polyunsaturated fatty acids during early human development</article-title>. <source>J Pediatr</source>. <year>1992</year>;<volume>120</volume>(<issue>4</issue>, <supplement>pt 2</supplement>):<fpage>S129</fpage>-<lpage>S138</lpage>.</citation>
</ref>
<ref id="bibr18-0148607112467821">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Singh</surname><given-names>M</given-names></name>
</person-group>. <article-title>Essential fatty acids, DHA and human brain</article-title>. <source>Indian J Pediatr</source>. <year>2005</year>;<volume>72</volume>(<issue>3</issue>):<fpage>239</fpage>-<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr19-0148607112467821">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Innis</surname><given-names>SM</given-names></name>
<name><surname>de La Presa Owens</surname><given-names>S</given-names></name>
</person-group>. <article-title>Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain</article-title>. <source>J Nutr</source>. <year>2001</year>;<volume>131</volume>(<issue>1</issue>):<fpage>118</fpage>-<lpage>122</lpage>.</citation>
</ref>
<ref id="bibr20-0148607112467821">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Auestad</surname><given-names>N</given-names></name>
<name><surname>Halter</surname><given-names>R</given-names></name>
<name><surname>Hall</surname><given-names>RT</given-names></name>
<etal/>
</person-group>. <article-title>Growth and development in term infants fed long-chain polyunsaturated fatty acids: a double-masked, randomized, parallel, prospective, multivariate study</article-title>. <source>Pediatrics</source>. <year>2001</year>;<volume>108</volume>(<issue>2</issue>):<fpage>372</fpage>-<lpage>381</lpage>.</citation>
</ref>
<ref id="bibr21-0148607112467821">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zimmer</surname><given-names>L</given-names></name>
<name><surname>Vancassel</surname><given-names>S</given-names></name>
<name><surname>Cantagrel</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>The dopamine mesocorticolimbic pathway is affected by deficiency in n-3 polyunsaturated fatty acids</article-title>. <source>Am J Clin Nutr</source>. <year>2002</year>;<volume>75</volume>(<issue>4</issue>):<fpage>662</fpage>-<lpage>667</lpage>.</citation>
</ref>
<ref id="bibr22-0148607112467821">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zicker</surname><given-names>SC</given-names></name>
<name><surname>Jewell</surname><given-names>DE</given-names></name>
<name><surname>Yamka</surname><given-names>RM</given-names></name>
<name><surname>Milgram</surname><given-names>NW</given-names></name>
</person-group>. <article-title>Evaluation of cognitive learning, memory, psychomotor, immunologic, and retinal functions in healthy puppies fed foods fortified with docosahexaenoic acid-rich fish oil from 8 to 52 weeks of age</article-title>. <source>J Am Vet Med Assoc</source>. <year>2012</year>;<volume>241</volume>(<issue>5</issue>):<fpage>583</fpage>-<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr23-0148607112467821">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yavin</surname><given-names>E</given-names></name>
<name><surname>Himovichi</surname><given-names>E</given-names></name>
<name><surname>Eilam</surname><given-names>R</given-names></name>
</person-group>. <article-title>Delayed cell migration in the developing rat brain following maternal omega 3 alpha linolenic acid dietary deficiency</article-title>. <source>Neuroscience</source>. <year>2009</year>;<volume>162</volume>(<issue>4</issue>):<fpage>1011</fpage>-<lpage>1022</lpage>.</citation>
</ref>
<ref id="bibr24-0148607112467821">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Helland</surname><given-names>IB</given-names></name>
<name><surname>Saugstad</surname><given-names>OD</given-names></name>
<name><surname>Smith</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women</article-title>. <source>Pediatrics</source>. <year>2001</year>;<volume>108</volume>(<issue>5</issue>):<fpage>E82</fpage>.</citation>
</ref>
<ref id="bibr25-0148607112467821">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Innis</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Essential fatty acid transfer and fetal development</article-title>. <source>Placenta</source>. <year>2005</year>;<volume>26</volume>(<supplement>suppl A</supplement>):<fpage>S70</fpage>-<lpage>S75</lpage>.</citation>
</ref>
<ref id="bibr26-0148607112467821">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>FM</given-names></name>
<name><surname>Bush</surname><given-names>PG</given-names></name>
<name><surname>Veerkamp</surname><given-names>JH</given-names></name>
<name><surname>Dutta-Roy</surname><given-names>AK</given-names></name>
</person-group>. <article-title>Detection and cellular localization of plasma membrane–associated and cytoplasmic fatty acid–binding proteins in human placenta</article-title>. <source>Placenta</source>. <year>1998</year>;<volume>19</volume>(<issue>5-6</issue>): <fpage>409</fpage>-<lpage>415</lpage>.</citation>
</ref>
<ref id="bibr27-0148607112467821">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>FM</given-names></name>
<name><surname>Gordon</surname><given-names>MJ</given-names></name>
<name><surname>Dutta-Roy</surname><given-names>AK</given-names></name>
</person-group>. <article-title>Preferential uptake of long chain polyunsaturated fatty acids by isolated human placental membranes</article-title>. <source>Mol Cell Biochem</source>. <year>1996</year>;<volume>155</volume>(<issue>1</issue>):<fpage>77</fpage>-<lpage>83</lpage>.</citation>
</ref>
<ref id="bibr28-0148607112467821">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dutta-Roy</surname><given-names>AK</given-names></name>
</person-group>. <article-title>Transport mechanisms for long-chain polyunsaturated fatty acids in the human placenta</article-title>. <source>Am J Clin Nutr</source>. <year>2000</year>;<volume>71</volume>(<issue>1</issue>)(<supplement>suppl</supplement>):<fpage>315S</fpage>-<lpage>322S</lpage>.</citation>
</ref>
<ref id="bibr29-0148607112467821">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crawford</surname><given-names>MA</given-names></name>
<name><surname>Hassam</surname><given-names>AG</given-names></name>
<name><surname>Williams</surname><given-names>G</given-names></name>
</person-group>. <article-title>Essential fatty acids and fetal brain growth</article-title>. <source>Lancet</source>. <year>1976</year>;<volume>1</volume>(<issue>7957</issue>):<fpage>452</fpage>-<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr30-0148607112467821">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shand</surname><given-names>JH</given-names></name>
<name><surname>Noble</surname><given-names>RC</given-names></name>
</person-group>. <article-title>The metabolism of 18:0 and 18:2(n-6) by the ovine placenta at 120 and 150 days of gestation</article-title>. <source>Lipids</source>. <year>1981</year>;<volume>16</volume>(<issue>1</issue>):<fpage>68</fpage>-<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr31-0148607112467821">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chambaz</surname><given-names>J</given-names></name>
<name><surname>Ravel</surname><given-names>D</given-names></name>
<name><surname>Manier</surname><given-names>MC</given-names></name>
<name><surname>Pepin</surname><given-names>D</given-names></name>
<name><surname>Mulliez</surname><given-names>N</given-names></name>
<name><surname>Bereziat</surname><given-names>G</given-names></name>
</person-group>. <article-title>Essential fatty acids interconversion in the human fetal liver</article-title>. <source>Biol Neonate</source>. <year>1985</year>;<volume>47</volume>(<issue>3</issue>):<fpage>136</fpage>-<lpage>140</lpage>.</citation>
</ref>
<ref id="bibr32-0148607112467821">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Larque</surname><given-names>E</given-names></name>
<name><surname>Demmelmair</surname><given-names>H</given-names></name>
<name><surname>Berger</surname><given-names>B</given-names></name>
<name><surname>Hasbargen</surname><given-names>U</given-names></name>
<name><surname>Koletzko</surname><given-names>B</given-names></name>
</person-group>. <article-title>In vivo investigation of the placental transfer of (13)C-labeled fatty acids in humans</article-title>. <source>J Lipid Res</source>. <year>2003</year>;<volume>44</volume>(<issue>1</issue>):<fpage>49</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr33-0148607112467821">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haggarty</surname><given-names>P</given-names></name>
<name><surname>Page</surname><given-names>K</given-names></name>
<name><surname>Abramovich</surname><given-names>DR</given-names></name>
<name><surname>Ashton</surname><given-names>J</given-names></name>
<name><surname>Brown</surname><given-names>D</given-names></name>
</person-group>. <article-title>Long-chain polyunsaturated fatty acid transport across the perfused human placenta</article-title>. <source>Placenta</source>. <year>1997</year>;<volume>18</volume>(<issue>8</issue>):<fpage>635</fpage>-<lpage>642</lpage>.</citation>
</ref>
<ref id="bibr34-0148607112467821">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Carnielli</surname><given-names>VP</given-names></name>
<name><surname>Wattimena</surname><given-names>DJ</given-names></name>
<name><surname>Luijendijk</surname><given-names>IH</given-names></name>
<name><surname>Boerlage</surname><given-names>A</given-names></name>
<name><surname>Degenhart</surname><given-names>HJ</given-names></name>
<name><surname>Sauer</surname><given-names>PJ</given-names></name>
</person-group>. <article-title>The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids</article-title>. <source>Pediatr Res</source>. <year>1996</year>;<volume>40</volume>(<issue>1</issue>):<fpage>169</fpage>-<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr35-0148607112467821">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pawlosky</surname><given-names>RJ</given-names></name>
<name><surname>Hibbeln</surname><given-names>JR</given-names></name>
<name><surname>Novotny</surname><given-names>JA</given-names></name>
<name><surname>Salem</surname><given-names>N</given-names></name>
</person-group> <article-title>Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans</article-title>. <source>J Lipid Res</source>. <year>2001</year>;<volume>42</volume>(<issue>8</issue>):<fpage>1257</fpage>-<lpage>1265</lpage>.</citation>
</ref>
<ref id="bibr36-0148607112467821">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Uauy</surname><given-names>R</given-names></name>
<name><surname>Mena</surname><given-names>P</given-names></name>
<name><surname>Wegher</surname><given-names>B</given-names></name>
<name><surname>Nieto</surname><given-names>S</given-names></name>
<name><surname>Salem</surname><given-names>N</given-names></name>
</person-group> <article-title>Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth</article-title>. <source>Pediatr Res</source>. <year>2000</year>;<volume>47</volume>(<issue>1</issue>):<fpage>127</fpage>-<lpage>135</lpage>.</citation>
</ref>
<ref id="bibr37-0148607112467821">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Su</surname><given-names>HM</given-names></name>
<name><surname>Huang</surname><given-names>MC</given-names></name>
<name><surname>Saad</surname><given-names>NM</given-names></name>
<name><surname>Nathanielsz</surname><given-names>PW</given-names></name>
<name><surname>Brenna</surname><given-names>JT</given-names></name>
</person-group>. <article-title>Fetal baboons convert 18:3n-3 to 22:6n-3 in vivo: a stable isotope tracer study</article-title>. <source>J Lipid Res</source>. <year>2001</year>;<volume>42</volume>(<issue>4</issue>):<fpage>581</fpage>-<lpage>586</lpage>.</citation>
</ref>
<ref id="bibr38-0148607112467821">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuipers</surname><given-names>RS</given-names></name>
<name><surname>Luxwolda</surname><given-names>MF</given-names></name>
<name><surname>Offringa</surname><given-names>PJ</given-names></name>
<etal/>
</person-group>. <article-title>Gestational age dependent content, composition and intrauterine accretion rates of fatty acids in fetal white adipose tissue</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source>. <year>2012</year>;<volume>86</volume>(<issue>1-2</issue>):<fpage>39</fpage>-<lpage>49</lpage>.</citation>
</ref>
<ref id="bibr39-0148607112467821">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Levitt</surname><given-names>P</given-names></name>
</person-group>. <article-title>Structural and functional maturation of the developing primate brain</article-title>. <source>J Pediatr</source>. <year>2003</year>;<volume>143</volume>(<issue>4</issue>)(<supplement>suppl</supplement>):<fpage>S35</fpage>-<lpage>S45</lpage>.</citation>
</ref>
<ref id="bibr40-0148607112467821">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brenna</surname><given-names>JT</given-names></name>
<name><surname>Varamini</surname><given-names>B</given-names></name>
<name><surname>Jensen</surname><given-names>RG</given-names></name>
<name><surname>Diersen-Schade</surname><given-names>DA</given-names></name>
<name><surname>Boettcher</surname><given-names>JA</given-names></name>
<name><surname>Arterburn</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>(<issue>6</issue>):<fpage>1457</fpage>-<lpage>1464</lpage>.</citation>
</ref>
<ref id="bibr41-0148607112467821">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Connor</surname><given-names>DL</given-names></name>
<name><surname>Hall</surname><given-names>R</given-names></name>
<name><surname>Adamkin</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial</article-title>. <source>Pediatrics</source>. <year>2001</year>;<volume>108</volume>(<issue>2</issue>):<fpage>359</fpage>-<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr42-0148607112467821">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>SanGiovanni</surname><given-names>JP</given-names></name>
<name><surname>Parra-Cabrera</surname><given-names>S</given-names></name>
<name><surname>Colditz</surname><given-names>GA</given-names></name>
<name><surname>Berkey</surname><given-names>CS</given-names></name>
<name><surname>Dwyer</surname><given-names>JT</given-names></name>
</person-group>. <article-title>Meta-analysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants</article-title>. <source>Pediatrics</source>. <year>2000</year>;<volume>105</volume>(<issue>6</issue>):<fpage>1292</fpage>-<lpage>1298</lpage>.</citation>
</ref>
<ref id="bibr43-0148607112467821">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Birch</surname><given-names>EE</given-names></name>
<name><surname>Carlson</surname><given-names>SE</given-names></name>
<name><surname>Hoffman</surname><given-names>DR</given-names></name>
<etal/>
</person-group>. <article-title>The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid</article-title>. <source>Am J Clin Nutr</source>. <year>2010</year>;<volume>91</volume>(<issue>4</issue>):<fpage>848</fpage>-<lpage>859</lpage>.</citation>
</ref>
<ref id="bibr44-0148607112467821">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jensen</surname><given-names>CL</given-names></name>
<name><surname>Voigt</surname><given-names>RG</given-names></name>
<name><surname>Llorente</surname><given-names>AM</given-names></name>
<etal/>
</person-group>. <article-title>Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants</article-title>. <source>J Pediatr</source>. <year>2010</year>;<volume>157</volume>(<issue>6</issue>):<fpage>900</fpage>-<lpage>905</lpage>.</citation>
</ref>
<ref id="bibr45-0148607112467821">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hibbeln</surname><given-names>JR</given-names></name>
<name><surname>Davis</surname><given-names>JM</given-names></name>
<name><surname>Steer</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>369</volume>(<issue>9561</issue>):<fpage>578</fpage>-<lpage>585</lpage>.</citation>
</ref>
<ref id="bibr46-0148607112467821">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bakker</surname><given-names>EC</given-names></name>
<name><surname>Hornstra</surname><given-names>G</given-names></name>
<name><surname>Blanco</surname><given-names>CE</given-names></name>
<name><surname>Vles</surname><given-names>JS</given-names></name>
</person-group>. <article-title>Relationship between long-chain polyunsaturated fatty acids at birth and motor function at 7 years of age</article-title>. <source>Eur J Clin Nutr</source>. <year>2009</year>;<volume>63</volume>(<issue>4</issue>):<fpage>499</fpage>-<lpage>504</lpage>.</citation>
</ref>
<ref id="bibr47-0148607112467821">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aberg</surname><given-names>MA</given-names></name>
<name><surname>Aberg</surname><given-names>N</given-names></name>
<name><surname>Brisman</surname><given-names>J</given-names></name>
<name><surname>Sundberg</surname><given-names>R</given-names></name>
<name><surname>Winkvist</surname><given-names>A</given-names></name>
<name><surname>Toren</surname><given-names>K</given-names></name>
</person-group>. <article-title>Fish intake of Swedish male adolescents is a predictor of cognitive performance</article-title>. <source>Acta Paediatr</source>. <year>2009</year>;<volume>98</volume>(<issue>3</issue>):<fpage>555</fpage>-<lpage>560</lpage>.</citation>
</ref>
<ref id="bibr48-0148607112467821">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jacques</surname><given-names>C</given-names></name>
<name><surname>Levy</surname><given-names>E</given-names></name>
<name><surname>Muckle</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children</article-title>. <source>J Pediatr</source>. <year>2011</year>;<volume>158</volume>(<issue>1</issue>):<fpage>83</fpage>-<lpage>90</lpage>, <fpage>90.e1</fpage>.</citation>
</ref>
<ref id="bibr49-0148607112467821">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Boucher</surname><given-names>O</given-names></name>
<name><surname>Burden</surname><given-names>MJ</given-names></name>
<name><surname>Muckle</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Neurophysiologic and neurobehavioral evidence of beneficial effects of prenatal omega-3 fatty acid intake on memory function at school age</article-title>. <source>Am J Clin Nutr</source>. <year>2011</year>;<volume>93</volume>(<issue>5</issue>):<fpage>1025</fpage>-<lpage>1037</lpage>.</citation>
</ref>
<ref id="bibr50-0148607112467821">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Minns</surname><given-names>LM</given-names></name>
<name><surname>Kerling</surname><given-names>EH</given-names></name>
<name><surname>Neely</surname><given-names>MR</given-names></name>
<etal/>
</person-group>. <article-title>Toddler formula supplemented with docosahexaenoic acid (DHA) improves DHA status and respiratory health in a randomized, double-blind, controlled trial of US children less than 3 years of age</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source>. <year>2010</year>;<volume>82</volume>(<issue>4-6</issue>):<fpage>287</fpage>-<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr51-0148607112467821">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campoy</surname><given-names>C</given-names></name>
<name><surname>Escolano-Margarit</surname><given-names>MV</given-names></name>
<name><surname>Anjos</surname><given-names>T</given-names></name>
<name><surname>Szajewska</surname><given-names>H</given-names></name>
<name><surname>Uauy</surname><given-names>R</given-names></name>
</person-group>. <article-title>Omega 3 fatty acids on child growth, visual acuity and neurodevelopment</article-title>. <source>Br J Nutr</source>. <year>2012</year>;<volume>107</volume>(<supplement>suppl 2</supplement>):<fpage>S85</fpage>-<lpage>S106</lpage>.</citation>
</ref>
<ref id="bibr52-0148607112467821">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ghys</surname><given-names>A</given-names></name>
<name><surname>Bakker</surname><given-names>E</given-names></name>
<name><surname>Hornstra</surname><given-names>G</given-names></name>
<name><surname>van den Hout</surname><given-names>M</given-names></name>
</person-group>. <article-title>Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age</article-title>. <source>Early Hum Dev</source>. <year>2002</year>;<volume>69</volume>(<issue>1-2</issue>):<fpage>83</fpage>-<lpage>90</lpage>.</citation>
</ref>
<ref id="bibr53-0148607112467821">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>AS</given-names></name>
<name><surname>Astwood</surname><given-names>JD</given-names></name>
<name><surname>Gautier</surname><given-names>S</given-names></name>
<name><surname>Kuratko</surname><given-names>CN</given-names></name>
<name><surname>Nelson</surname><given-names>EB</given-names></name>
<name><surname>Salem</surname><given-names>N</given-names></name>
</person-group>. <article-title>Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source>. <year>2010</year>;<volume>82</volume>(<issue>4-6</issue>):<fpage>305</fpage>-<lpage>314</lpage>.</citation>
</ref>
<ref id="bibr54-0148607112467821">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donahue</surname><given-names>SM</given-names></name>
<name><surname>Rifas-Shiman</surname><given-names>SL</given-names></name>
<name><surname>Gold</surname><given-names>DR</given-names></name>
<name><surname>Jouni</surname><given-names>ZE</given-names></name>
<name><surname>Gillman</surname><given-names>MW</given-names></name>
<name><surname>Oken</surname><given-names>E</given-names></name>
</person-group>. <article-title>Prenatal fatty acid status and child adiposity at age 3 y: results from a US pregnancy cohort</article-title>. <source>Am J Clin Nutr</source>. <year>2011</year>;<volume>93</volume>(<issue>4</issue>):<fpage>780</fpage>-<lpage>788</lpage>.</citation>
</ref>
<ref id="bibr55-0148607112467821">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Innis</surname><given-names>SM</given-names></name>
</person-group>. <article-title>Metabolic programming of long-term outcomes due to fatty acid nutrition in early life</article-title>. <source>Maternal Child Nutr</source>. <year>2011</year>;<volume>7</volume>(<supplement>suppl 2</supplement>):<fpage>112</fpage>-<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr56-0148607112467821">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ailhaud</surname><given-names>G</given-names></name>
<name><surname>Guesnet</surname><given-names>P</given-names></name>
<name><surname>Cunnane</surname><given-names>SC</given-names></name>
</person-group>. <article-title>An emerging risk factor for obesity: does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development?</article-title> <source>Br J Nutr</source>. <year>2008</year>;<volume>100</volume>(<issue>3</issue>):<fpage>461</fpage>-<lpage>470</lpage>.</citation>
</ref>
<ref id="bibr57-0148607112467821">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bouret</surname><given-names>SG</given-names></name>
</person-group>. <article-title>Role of early hormonal and nutritional experiences in shaping feeding behavior and hypothalamic development</article-title>. <source>J Nutr</source>. <year>2010</year>;<volume>140</volume>(<issue>3</issue>):<fpage>653</fpage>-<lpage>657</lpage>.</citation>
</ref>
<ref id="bibr58-0148607112467821">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>N</given-names></name>
<name><surname>Dhanwal</surname><given-names>D</given-names></name>
<name><surname>Robinson</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Does maternal long chain polyunsaturated fatty acid status in pregnancy influence the bone health of children? The Southampton Women’s Survey</article-title>. <source>Osteoporos Int</source>. <year>2012</year>;<volume>23</volume>(<issue>9</issue>):<fpage>2359</fpage>-<lpage>2367</lpage>.</citation>
</ref>
<ref id="bibr59-0148607112467821">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Milte</surname><given-names>CM</given-names></name>
<name><surname>Parletta</surname><given-names>N</given-names></name>
<name><surname>Buckley</surname><given-names>JD</given-names></name>
<name><surname>Coates</surname><given-names>AM</given-names></name>
<name><surname>Young</surname><given-names>RM</given-names></name>
<name><surname>Howe</surname><given-names>PR</given-names></name>
</person-group>. <article-title>Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial</article-title>. <source>Nutrition</source>. <year>2012</year>;<volume>28</volume>(<issue>6</issue>):<fpage>670</fpage>-<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr60-0148607112467821">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Birch</surname><given-names>EE</given-names></name>
<name><surname>Khoury</surname><given-names>JC</given-names></name>
<name><surname>Berseth</surname><given-names>CL</given-names></name>
<etal/>
</person-group>. <article-title>The impact of early nutrition on incidence of allergic manifestations and common respiratory illnesses in children</article-title>. <source>J Pediatr</source>. <year>2010</year>;<volume>156</volume>(<issue>6</issue>):<fpage>902</fpage>-<lpage>906</lpage>, <fpage>906.e1</fpage>.</citation>
</ref>
<ref id="bibr61-0148607112467821">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Agrawal</surname><given-names>R</given-names></name>
<name><surname>Gomez-Pinilla</surname><given-names>F</given-names></name>
</person-group>. <article-title>‘Metabolic syndrome’ in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition</article-title>. <source>J Physiol</source>. <year>2012</year>;<volume>590</volume>(<issue>pt 10</issue>):<fpage>2485</fpage>-<lpage>2499</lpage>.</citation>
</ref>
<ref id="bibr62-0148607112467821">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muldoon</surname><given-names>MF</given-names></name>
<name><surname>Ryan</surname><given-names>CM</given-names></name>
<name><surname>Sheu</surname><given-names>L</given-names></name>
<name><surname>Yao</surname><given-names>JK</given-names></name>
<name><surname>Conklin</surname><given-names>SM</given-names></name>
<name><surname>Manuck</surname><given-names>SB</given-names></name>
</person-group>. <article-title>Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood</article-title>. <source>J Nutr</source>. <year>2010</year>;<volume>140</volume>(<issue>4</issue>):<fpage>848</fpage>-<lpage>853</lpage>.</citation>
</ref>
<ref id="bibr63-0148607112467821">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kalmijn</surname><given-names>S</given-names></name>
<name><surname>van Boxtel</surname><given-names>MP</given-names></name>
<name><surname>Ocke</surname><given-names>M</given-names></name>
<name><surname>Verschuren</surname><given-names>WM</given-names></name>
<name><surname>Kromhout</surname><given-names>D</given-names></name>
<name><surname>Launer</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>Dietary intake of fatty acids and fish in relation to cognitive performance at middle age</article-title>. <source>Neurology</source>. <year>2004</year>;<volume>62</volume>(<issue>2</issue>):<fpage>275</fpage>-<lpage>280</lpage>.</citation>
</ref>
<ref id="bibr64-0148607112467821">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Eskelinen</surname><given-names>MH</given-names></name>
<name><surname>Ngandu</surname><given-names>T</given-names></name>
<name><surname>Helkala</surname><given-names>EL</given-names></name>
<etal/>
</person-group>. <article-title>Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study</article-title>. <source>Int J Geriatr Psychiatry</source>. <year>2008</year>;<volume>23</volume>(<issue>7</issue>):<fpage>741</fpage>-<lpage>747</lpage>.</citation>
</ref>
<ref id="bibr65-0148607112467821">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beydoun</surname><given-names>MA</given-names></name>
<name><surname>Kaufman</surname><given-names>JS</given-names></name>
<name><surname>Satia</surname><given-names>JA</given-names></name>
<name><surname>Rosamond</surname><given-names>W</given-names></name>
<name><surname>Folsom</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>85</volume>(<issue>4</issue>):<fpage>1103</fpage>-<lpage>1111</lpage>.</citation>
</ref>
<ref id="bibr66-0148607112467821">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heude</surname><given-names>B</given-names></name>
<name><surname>Ducimetiere</surname><given-names>P</given-names></name>
<name><surname>Berr</surname><given-names>C</given-names></name>
</person-group>. <article-title>Cognitive decline and fatty acid composition of erythrocyte membranes: the EVA Study</article-title>. <source>Am J Clin Nutr</source>. <year>2003</year>;<volume>77</volume>(<issue>4</issue>):<fpage>803</fpage>-<lpage>808</lpage>.</citation>
</ref>
<ref id="bibr67-0148607112467821">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dullemeijer</surname><given-names>C</given-names></name>
<name><surname>Durga</surname><given-names>J</given-names></name>
<name><surname>Brouwer</surname><given-names>IA</given-names></name>
<etal/>
</person-group>. <article-title>n 3 fatty acid proportions in plasma and cognitive performance in older adults</article-title>. <source>Am J Clin Nutr</source>. <year>2007</year>;<volume>86</volume>(<issue>5</issue>):<fpage>1479</fpage>-<lpage>1485</lpage>.</citation>
</ref>
<ref id="bibr68-0148607112467821">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leeson</surname><given-names>CP</given-names></name>
<name><surname>Mann</surname><given-names>A</given-names></name>
<name><surname>Kattenhorn</surname><given-names>M</given-names></name>
<name><surname>Deanfield</surname><given-names>JE</given-names></name>
<name><surname>Lucas</surname><given-names>A</given-names></name>
<name><surname>Muller</surname><given-names>DP</given-names></name>
</person-group>. <article-title>Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood</article-title>. <source>Eur Heart J</source>. <year>2002</year>;<volume>23</volume>(<issue>3</issue>):<fpage>216</fpage>-<lpage>222</lpage>.</citation>
</ref>
<ref id="bibr69-0148607112467821">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dean</surname><given-names>M</given-names></name>
<name><surname>Raats</surname><given-names>MM</given-names></name>
<name><surname>Grunert</surname><given-names>KG</given-names></name>
<name><surname>Lumbers</surname><given-names>M</given-names></name>
</person-group>. <article-title>Factors influencing eating a varied diet in old age</article-title>. <source>Public Health Nutr</source>. <year>2009</year>;<volume>12</volume>(<issue>12</issue>):<fpage>2421</fpage>-<lpage>2427</lpage>.</citation>
</ref>
<ref id="bibr70-0148607112467821">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ubeda</surname><given-names>N</given-names></name>
<name><surname>Achon</surname><given-names>M</given-names></name>
<name><surname>Varela-Moreiras</surname><given-names>G</given-names></name>
</person-group>. <article-title>Omega 3 fatty acids in the elderly</article-title>. <source>Br J Nutr</source>. <year>2012</year>;<volume>107</volume>(<supplement>suppl 2</supplement>):<fpage>S137</fpage>-<lpage>S151</lpage>.</citation>
</ref>
<ref id="bibr71-0148607112467821">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barker</surname><given-names>DJ</given-names></name>
<name><surname>Martyn</surname><given-names>CN</given-names></name>
</person-group>. <article-title>The maternal and fetal origins of cardiovascular disease</article-title>. <source>J Epidemiol Commun Health</source>. <year>1992</year>;<volume>46</volume>(<issue>1</issue>):<fpage>8</fpage>-<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr72-0148607112467821">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Meydani</surname><given-names>SN</given-names></name>
<name><surname>Endres</surname><given-names>S</given-names></name>
<name><surname>Woods</surname><given-names>MM</given-names></name>
<etal/>
</person-group>. <article-title>Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women</article-title>. <source>J Nutr</source>. <year>1991</year>;<volume>121</volume>(<issue>4</issue>):<fpage>547</fpage>-<lpage>555</lpage>.</citation>
</ref>
<ref id="bibr73-0148607112467821">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pae</surname><given-names>M</given-names></name>
<name><surname>Meydani</surname><given-names>SN</given-names></name>
<name><surname>Wu</surname><given-names>D</given-names></name>
</person-group>. <article-title>The role of nutrition in enhancing immunity in aging</article-title>. <source>Aging Dis</source>. <year>2012</year>;<volume>3</volume>(<issue>1</issue>):<fpage>91</fpage>-<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr74-0148607112467821">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rojas</surname><given-names>CV</given-names></name>
<name><surname>Martinez</surname><given-names>JI</given-names></name>
<name><surname>Flores</surname><given-names>I</given-names></name>
<name><surname>Hoffman</surname><given-names>DR</given-names></name>
<name><surname>Uauy</surname><given-names>R</given-names></name>
</person-group>. <article-title>Gene expression analysis in human fetal retinal explants treated with docosahexaenoic acid</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2003</year>;<volume>44</volume>(<issue>7</issue>):<fpage>3170</fpage>-<lpage>3177</lpage>.</citation>
</ref>
<ref id="bibr75-0148607112467821">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lukiw</surname><given-names>WJ</given-names></name>
<name><surname>Bazan</surname><given-names>NG</given-names></name>
</person-group>. <article-title>Docosahexaenoic acid and the aging brain</article-title>. <source>J Nutr</source>. <year>2008</year>;<volume>138</volume>(<issue>12</issue>):<fpage>2510</fpage>-<lpage>2514</lpage>.</citation>
</ref>
<ref id="bibr76-0148607112467821">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wood</surname><given-names>JT</given-names></name>
<name><surname>Williams</surname><given-names>JS</given-names></name>
<name><surname>Pandarinathan</surname><given-names>L</given-names></name>
<name><surname>Janero</surname><given-names>DR</given-names></name>
<name><surname>Lammi-Keefe</surname><given-names>CJ</given-names></name>
<name><surname>Makriyannis</surname><given-names>A</given-names></name>
</person-group>. <article-title>Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma</article-title>. <source>J Lipid Res</source>. <year>2010</year>;<volume>51</volume>(<issue>6</issue>):<fpage>1416</fpage>-<lpage>1423</lpage>.</citation>
</ref>
<ref id="bibr77-0148607112467821">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Musiek</surname><given-names>ES</given-names></name>
<name><surname>Brooks</surname><given-names>JD</given-names></name>
<name><surname>Joo</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>29</issue>):<fpage>19927</fpage>-<lpage>19935</lpage>.</citation>
</ref>
<ref id="bibr78-0148607112467821">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Song</surname><given-names>WL</given-names></name>
<name><surname>Lawson</surname><given-names>JA</given-names></name>
<name><surname>Reilly</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Neurofurans, novel indices of oxidant stress derived from docosahexaenoic acid</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>1</issue>):<fpage>6</fpage>-<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr79-0148607112467821">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tan</surname><given-names>ZS</given-names></name>
<name><surname>Harris</surname><given-names>WS</given-names></name>
<name><surname>Beiser</surname><given-names>AS</given-names></name>
<etal/>
</person-group>. <article-title>Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging</article-title>. <source>Neurology</source>. <year>2012</year>;<volume>78</volume>(<issue>9</issue>):<fpage>658</fpage>-<lpage>664</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>